Merck Live Press Feed
-
AMM Announces The Doctors' Choice Awards Finalists: Over 4,600 MDs Vote for Best Journal Ads in AMM's Doctors' Choice Awards
AMM Announces The Doctors' Choice Awards Finalists: Over 4,600 MDs Vote for Best Journal Ads in AMM's Doctors' Choice Awards PR Newswire MOUNT LAUREL, N.J. , Sept. 1 /PRNewswire-USNewswire/ -- The Association of Medical Media...
-
Results From Investigator-Sponsored Trials Presented at SSIEM Conference
Results From Investigator-Sponsored Trials Presented at SSIEM Conference Kuvan Patients Show Improvements in Neurocognitive Functioning, Mood and Behavior PR Newswire NOVATO, Calif. , Sept. 1 /PRNewswire-FirstCall/ -- BioMarin...
-
US Educational Support Service for MS Community, MS LifeLines(R), Reaches Milestone of Servicing one Million In-bound Calls
US Educational Support Service for MS Community, MS LifeLines(R), Reaches Milestone of Servicing one Million In-bound Calls PR Newswire GENEVA , September 1, 2010 /PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt,...
-
MS LifeLines® Reaches Milestone of Servicing One Million In-Bound Calls
MS LifeLines® Reaches Milestone of Servicing One Million In-Bound Calls Educational Support Service for Multiple Sclerosis Community Provides a Voice at the Other End PR Newswire ROCKLAND, Mass. and NEW YORK , Sept. 1 /PRNewswire-FirstCall/...
-
Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017
Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 PR Newswire NEW YORK , Aug. 31 /PRNewswire/ Reportlinker.com announces that a new market research report is available...
-
Reportlinker Adds Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma
Reportlinker Adds Epigenetics Therapeutics to 2017 - High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma PR Newswire NEW YORK , Aug. 31 /PRNewswire/ -- Reportlinker.com...
-
Reportlinker Adds Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
Reportlinker Adds Women's Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets PR Newswire NEW YORK , Aug. 31 /PRNewswire/...
-
Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012
Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 PR Newswire NEW YORK , Aug. 31 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: E7: The Outlook for Pharmaceuticals...
-
Reportlinker Adds Women's Infertility - Pipeline Assessment and Market Forecasts to 2017
Reportlinker Adds Women's Infertility - Pipeline Assessment and Market Forecasts to 2017 PR Newswire NEW YORK , Aug. 31 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:...
-
Hot US Stocks Alert: (RPC, Gilead Sciences, Inc., ArcSight Inc., Boston Merck & Co., Inc.)
( EMAILWIRE.COM , August 30, 2010 ) New York, NY-Radient Pharmaceuticals Corporation (AMEX:RPC) soared 33.87% to $0.830 on over 6.91 million shares after it announced the target market details for the domestic and international commercialization...
-
Critical Alerts for Exxon Mobil, Merck, Simon Property, CBS, and Republic Services Released by Seven Summits Research
Critical Alerts for Exxon Mobil, Merck, Simon Property, CBS, and Republic Services Released by Seven Summits Research PR Newswire CHICAGO , Aug. 30 /PRNewswire/ -- Seven Summits Research issues critical PriceWatch Alerts for XOM,...
-
BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease PR Newswire NOVATO, Calif. , Aug. 30 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that...
-
Dr. Cameron Durrant named one of PharmaVOICE's 100 most inspiring people in the pharmaceutical industry for 2010
Dr. Cameron Durrant named one of PharmaVOICE's 100 most inspiring people in the pharmaceutical industry for 2010 PR Newswire Recognized for leadership, innovation in annual ranking of top 100 industry professionals CALIFON,...
-
InfoLogix Positioned for Strategic Initiatives in Second Half of 2010
InfoLogix Positioned for Strategic Initiatives in Second Half of 2010 PR Newswire HATBORO, Pa. , Aug. 26 /PRNewswire-FirstCall/ -- InfoLogix, Inc. (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions...
-
4 out of 5 Physicians Online Visited Health Care Professional Sites in Q1 2010
4 out of 5 Physicians Online Visited Health Care Professional Sites in Q1 2010 Medscape.com Ranks as Most-Visited Health-Related Destination by Physicians, Reaching More than Half of Doctors Online comScore Releases First in a Series...
Presswire
- Pokersignupcodes.net Offers Free $50 to New Players at Absolute Poker/Ultimate Bet [09 Sep 2010] 24-7 pressrelease
- Underground Elephant Announces Addition of Former LeadPoint Engineer, Alex Chang [09 Sep 2010] 24-7 pressrelease



